Cargando…

Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation

A total number of 339 patients who received a pacemaker implantation between June 2012 and June 2014 at Tongji Hospital of Tongji Medical College (Wuhan, China) were investigated in the present study. The aims of the present study were to explore the risk factors of pocket hematoma following pacemak...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yang, Duan, Jialin, Wang, Lin, Bai, Rong, Lin, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450729/
https://www.ncbi.nlm.nih.gov/pubmed/28587353
http://dx.doi.org/10.3892/etm.2017.4366
_version_ 1783240046763048960
author Bai, Yang
Duan, Jialin
Wang, Lin
Bai, Rong
Lin, Li
author_facet Bai, Yang
Duan, Jialin
Wang, Lin
Bai, Rong
Lin, Li
author_sort Bai, Yang
collection PubMed
description A total number of 339 patients who received a pacemaker implantation between June 2012 and June 2014 at Tongji Hospital of Tongji Medical College (Wuhan, China) were investigated in the present study. The aims of the present study were to explore the risk factors of pocket hematoma following pacemaker implantation, and to analyze the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation. Predictors of hematoma occurrence were determined and analyzed via a Chi-square test. Patients suffering from pocket hematoma, which were indicated to be partially caused by an allergic reaction to the pacemaker component, were distinguished by routine blood parameters. Furthermore, the pacemaker component was distinguished by histopathological examinations in one patient. Promethazine (25 mg/day) was used to treat allergic patients. The results demonstrated that in patients with a history of allergies, the rate of pocket hematoma was significantly higher when compared with patients without a history of allergies (22.00 vs. 7.61%; P=0.027). A significantly increased incidence of hematoma was indicated in patients with a lower body mass index when compared with patients of normal weight (15.79 vs. 7.38%; P=0.042). Furthermore, implantation of larger-sized devices, such as an implantable cardioverter-defibrillator and cardiac resynchronization therapy, were significantly predictive of hematoma development (29.63 vs. 8.01%; P=0.015). Patients with diabetes were also identified to exhibit a significantly high incidence of hematoma (22.22 vs. 8.25%; P=0.023). Promethazine administration significantly decreased the incidence of re-operating (P=0.017) and the duration of hospital stay (P=0.038) in patients whose pocket hematoma was caused by an allergy. In conclusion, promethazine may be a beneficial agent to treat pocket hematoma caused by allergic reactions following pacemaker surgery.
format Online
Article
Text
id pubmed-5450729
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-54507292017-06-05 Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation Bai, Yang Duan, Jialin Wang, Lin Bai, Rong Lin, Li Exp Ther Med Articles A total number of 339 patients who received a pacemaker implantation between June 2012 and June 2014 at Tongji Hospital of Tongji Medical College (Wuhan, China) were investigated in the present study. The aims of the present study were to explore the risk factors of pocket hematoma following pacemaker implantation, and to analyze the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation. Predictors of hematoma occurrence were determined and analyzed via a Chi-square test. Patients suffering from pocket hematoma, which were indicated to be partially caused by an allergic reaction to the pacemaker component, were distinguished by routine blood parameters. Furthermore, the pacemaker component was distinguished by histopathological examinations in one patient. Promethazine (25 mg/day) was used to treat allergic patients. The results demonstrated that in patients with a history of allergies, the rate of pocket hematoma was significantly higher when compared with patients without a history of allergies (22.00 vs. 7.61%; P=0.027). A significantly increased incidence of hematoma was indicated in patients with a lower body mass index when compared with patients of normal weight (15.79 vs. 7.38%; P=0.042). Furthermore, implantation of larger-sized devices, such as an implantable cardioverter-defibrillator and cardiac resynchronization therapy, were significantly predictive of hematoma development (29.63 vs. 8.01%; P=0.015). Patients with diabetes were also identified to exhibit a significantly high incidence of hematoma (22.22 vs. 8.25%; P=0.023). Promethazine administration significantly decreased the incidence of re-operating (P=0.017) and the duration of hospital stay (P=0.038) in patients whose pocket hematoma was caused by an allergy. In conclusion, promethazine may be a beneficial agent to treat pocket hematoma caused by allergic reactions following pacemaker surgery. D.A. Spandidos 2017-06 2017-04-20 /pmc/articles/PMC5450729/ /pubmed/28587353 http://dx.doi.org/10.3892/etm.2017.4366 Text en Copyright: © Bai et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Bai, Yang
Duan, Jialin
Wang, Lin
Bai, Rong
Lin, Li
Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
title Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
title_full Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
title_fullStr Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
title_full_unstemmed Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
title_short Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
title_sort clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450729/
https://www.ncbi.nlm.nih.gov/pubmed/28587353
http://dx.doi.org/10.3892/etm.2017.4366
work_keys_str_mv AT baiyang clinicalanalysisoftheeffectofantiallergytreatmentonpocketrelatedcomplicationsfollowingpacemakerimplantation
AT duanjialin clinicalanalysisoftheeffectofantiallergytreatmentonpocketrelatedcomplicationsfollowingpacemakerimplantation
AT wanglin clinicalanalysisoftheeffectofantiallergytreatmentonpocketrelatedcomplicationsfollowingpacemakerimplantation
AT bairong clinicalanalysisoftheeffectofantiallergytreatmentonpocketrelatedcomplicationsfollowingpacemakerimplantation
AT linli clinicalanalysisoftheeffectofantiallergytreatmentonpocketrelatedcomplicationsfollowingpacemakerimplantation